637 related articles for article (PubMed ID: 36851614)
1. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID.
Vojdani A; Vojdani E; Saidara E; Maes M
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851614
[TBL] [Abstract][Full Text] [Related]
2. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
Front Immunol; 2022; 13():949787. PubMed ID: 36341457
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome.
Vojdani A; Almulla AF; Zhou B; Al-Hakeim HK; Maes M
Acta Neuropsychiatr; 2024 Jun; 36(3):172-184. PubMed ID: 38571295
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?
Ruiz-Pablos M; Paiva B; Zabaleta A
J Transl Med; 2023 Sep; 21(1):633. PubMed ID: 37718435
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
6. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Campen CLMCV; Rowe PC; Visser FC
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
[No Abstract] [Full Text] [Related]
7. Post-COVID sequelae effect in chronic fatigue syndrome: SARS-CoV-2 triggers latent adenovirus in the oral mucosa.
Hannestad U; Apostolou E; Sjögren P; Bragée B; Polo O; Bertilson BC; Rosén A
Front Med (Lausanne); 2023; 10():1208181. PubMed ID: 37457558
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
9. Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Kerr J
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114612
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.
Ruiz-Pablos M; Paiva B; Montero-Mateo R; Garcia N; Zabaleta A
Front Immunol; 2021; 12():656797. PubMed ID: 34867935
[TBL] [Abstract][Full Text] [Related]
11. Long Covid.
Zaidi AK; Dehgani-Mobaraki P
Prog Mol Biol Transl Sci; 2024; 202():113-125. PubMed ID: 38237983
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
Nunes JM; Kell DB; Pretorius E
Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
[TBL] [Abstract][Full Text] [Related]
13. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
Ariza ME
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572802
[TBL] [Abstract][Full Text] [Related]
14. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Sukocheva OA; Maksoud R; Beeraka NM; Madhunapantula SV; Sinelnikov M; Nikolenko VN; Neganova ME; Klochkov SG; Amjad Kamal M; Staines DR; Marshall-Gradisnik S
J Adv Res; 2022 Sep; 40():179-196. PubMed ID: 36100326
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
Elife; 2023 Mar; 12():. PubMed ID: 36947108
[TBL] [Abstract][Full Text] [Related]
16. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
[TBL] [Abstract][Full Text] [Related]
17. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
19. Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID.
Tate WP; Walker MOM; Peppercorn K; Blair ALH; Edgar CD
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982194
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
